Marder K - Search Results

1

Friedman D, Hamberger M, Stern Y, Marder K. Friedman D, et al. Among authors: marder k. J Clin Exp Neuropsychol. 1992 Jul;14(4):448-62. doi: 10.1080/01688639208402837. J Clin Exp Neuropsychol. 1992. PMID: 1400911

2

A 10-item smell identification scale related to risk for Alzheimer's disease.

Tabert MH, Liu X, Doty RL, Serby M, Zamora D, Pelton GH, Marder K, Albers MW, Stern Y, Devanand DP. Tabert MH, et al. Among authors: marder k. Ann Neurol. 2005 Jul;58(1):155-60. doi: 10.1002/ana.20533. Ann Neurol. 2005. PMID: 15984022

3

Double-blind parallel design pilot study of acetyl levocarnitine in patients with Alzheimer's disease.

Sano M, Bell K, Cote L, Dooneief G, Lawton A, Legler L, Marder K, Naini A, Stern Y, Mayeux R. Sano M, et al. Among authors: marder k. Arch Neurol. 1992 Nov;49(11):1137-41. doi: 10.1001/archneur.1992.00530350051019. Arch Neurol. 1992. PMID: 1444880 Clinical Trial.

4

The Columbia University Scale for Psychopathology in Alzheimer's disease.

Devanand DP, Miller L, Richards M, Marder K, Bell K, Mayeux R, Stern Y. Devanand DP, et al. Among authors: marder k. Arch Neurol. 1992 Apr;49(4):371-6. doi: 10.1001/archneur.1992.00530280051022. Arch Neurol. 1992. PMID: 1558517

5

Interrater reliability of extrapyramidal signs in a group assessed for dementia.

Richards M, Marder K, Bell K, Dooneief G, Mayeux R, Stern Y. Richards M, et al. Among authors: marder k. Arch Neurol. 1991 Nov;48(11):1147-9. doi: 10.1001/archneur.1991.00530230055021. Arch Neurol. 1991. PMID: 1953399

6

Neuropsychological detection and characterization of preclinical Alzheimer's disease.

Jacobs DM, Sano M, Dooneief G, Marder K, Bell KL, Stern Y. Jacobs DM, et al. Among authors: marder k. Neurology. 1995 May;45(5):957-62. doi: 10.1212/wnl.45.5.957. Neurology. 1995. PMID: 7746414

7

Age at onset of Alzheimer's disease: relation to pattern of cognitive dysfunction and rate of decline.

Jacobs D, Sano M, Marder K, Bell K, Bylsma F, Lafleche G, Albert M, Brandt J, Stern Y. Jacobs D, et al. Among authors: marder k. Neurology. 1994 Jul;44(7):1215-20. doi: 10.1212/wnl.44.7.1215. Neurology. 1994. PMID: 8035918

8

Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs.

Richards M, Bell K, Dooneief G, Marder K, Sano M, Mayeux R, Stern Y. Richards M, et al. Among authors: marder k. Neurology. 1993 Sep;43(9):1708-11. doi: 10.1212/wnl.43.9.1708. Neurology. 1993. PMID: 8414017

9

Safety and efficacy of oral physostigmine in the treatment of Alzheimer disease.

Sano M, Bell K, Marder K, Stricks L, Stern Y, Mayeux R. Sano M, et al. Among authors: marder k. Clin Neuropharmacol. 1993 Feb;16(1):61-9. doi: 10.1097/00002826-199302000-00007. Clin Neuropharmacol. 1993. PMID: 8422658 Clinical Trial.

10

Modeling the influence of extrapyramidal signs on the progression of Alzheimer disease.

Stern Y, Liu X, Albert M, Brandt J, Jacobs DM, Del Castillo-Castaneda C, Marder K, Bell K, Sano M, Bylsma F. Stern Y, et al. Among authors: marder k. Arch Neurol. 1996 Nov;53(11):1121-6. doi: 10.1001/archneur.1996.00550110061013. Arch Neurol. 1996. PMID: 8912485

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

503 results

Search Page

Filters